Company/Estimate
- (FUL)/.34
Bear Stearns Cos. (BSC): fell 4 percent to $10.78, the lowest in a week on March 28. Chairman James ``Jimmy'' Cayne sold 5.6 million shares, or his entire stake in the company, for $10.84 each on March 25, according to a regulatory filing last week.
Clear Channel Communications Inc. (CCU) said last week its sale to private-equity firms may collapse after banks backed out of financing the $19.5 billion deal. Clear Channel dropped 1.4 percent to $29.20 on March 28.
Citigroup Inc. (C) fell for a third day, dropping 4.4 percent to $20.83 on March 28. Oppenheimer & Co.'s Meredith Whitney, who predicted the largest U.S. bank's first-ever dividend cut earlier this year, said a second reduction is likely.
Delta Air Lines Inc. (DAL) rose the most in six days, gaining 3.1 percent to $8.61 on March 28 after the Wall Street Journal reported that Northwest Airlines Corp. (NWA) is trying to restart merger talks with a proposal that may provide less pay for pilots. Delta, Northwest and Continental Airlines Inc. began flights into London Heathrow today as a new ``Open Skies'' treaty expands trans-Atlantic air travel.
Northwest climbed 3.6 percent, to $8.76 and Continental (CAL) was up 7 cents to $19.08.
Lehman Brothers Holdings Inc. (LEH) said it plans to sue Marubeni Corp. to recover ``fraudulently misappropriated'' funds that newspaper reports say amount to more than $250 million. Lehman fell 2.2 percent to $37.87 on March 28.
Maguire Properties Inc. (MPG) said last week it's no longer trying to sell itself because turmoil in the credit markets deterred buyers. Maguire had the biggest decline since its initial public offering in June 2003, sliding 16 percent to $14.33 on March 28.
Radian Group Inc. (RDN) said last week its primary subsidiary would no longer provide coverage on loans where borrowers don't provide proof of income or assets. Radian dropped 7.4 percent to $6.73.
Schering-Plough Corp. (SGP): Vytorin, the cholesterol pill the company is working on with Merck & Co. (MRK:US), didn't slow clogging of the arteries better than an older, cheaper drug, prompting doctors to say the medicine should be used only as a last resort, a study showed.
Schering-Plough rose 0.9 percent to $19.47 on March 28 while Merck fell 0.6 percent to $44.51.
Tenet Healthcare Corp. (THC) rose the most in the Standard & Poor's 500 Index, climbing 4 percent to $5.51 on March 28. The second-biggest publicly held U.S. hospital chain will probably beat some analysts' forecasts for first-quarter results because of ``solid pricing, seasonably strong volume growth and good cost control,'' Deutsche Bank AG analysts including Darren Lehrich wrote in a note last week, after meeting with the company's management.
U.S. Steel Corp. (X) had the second-biggest gain in the Standard & Poor's 500 Index, advancing 3.4 percent to $125.69 on March 28. The biggest U.S. based steelmaker last week was raised to ``buy'' from ``neutral'' at Merrill Lynch & Co., which cited higher prices for the metal.
